Novartis AG
Patents, Design & Utilities

Last updated:

List of all Novartis AG patents 1,223 in total

Status Patent
Application
Utility: PHARMACEUTICAL COMBINATION COMPRISING TNO155 AND RIBOCICLIB External link
Filling date: 23 Sep 2025 Issue date: 26 May 2022
Application
Utility: PHARMACEUTICAL COMBINATION COMPRISING TNO155 AND A PD-1 INHIBITOR External link
Filling date: 23 Sep 2025 Issue date: 26 May 2022
Grant
Utility: Glycoside derivatives and uses thereof External link
Filling date: 23 Sep 2025 Issue date: 24 May 2022
Grant
Utility: Compositions, methods, and therapeutic uses related to fusogenic protein minion External link
Filling date: 23 Sep 2025 Issue date: 24 May 2022
Grant
Utility: Compounds and compositions for treating conditions associated with NLRP activity External link
Filling date: 23 Sep 2025 Issue date: 24 May 2022
Application
Utility: Choline Esters External link
Filling date: 23 Sep 2025 Issue date: 19 May 2022
Application
Utility: NOVEL USES OF PIPERIDINYL-INDOLE DERIVATIVES External link
Filling date: 23 Sep 2025 Issue date: 19 May 2022
Application
Utility: COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3 External link
Filling date: 23 Sep 2025 Issue date: 19 May 2022
Application
Utility: COMPOSITIONS AND METHODS TO TREAT BIETTI CRYSTALLINE DYSTROPHY External link
Filling date: 23 Sep 2025 Issue date: 19 May 2022
Application
Utility: COMPOSITIONS AND METHODS TO TREAT BIETTI CRYSTALLINE DYSTROPHY External link
Filling date: 23 Sep 2025 Issue date: 19 May 2022
Application
Utility: MESOPOROUS SILICA PARTICLES COMPOSITIONS FOR VIRAL DELIVERY External link
Filling date: 23 Sep 2025 Issue date: 19 May 2022
Application
Utility: PHARMACEUTICAL COMBINATION COMPRISING TNO155 AND A KRASG12C INHIBITOR External link
Filling date: 23 Sep 2025 Issue date: 19 May 2022
Grant
Utility: Multiple illumination transmission through optical fiber External link
Filling date: 23 Sep 2025 Issue date: 17 May 2022
Application
Utility: COMBINATION THERAPY External link
Filling date: 23 Sep 2025 Issue date: 12 May 2022
Application
Utility: OPTIMIZED LENTIVIRAL TRANSFER VECTORS AND USES THEREOF External link
Filling date: 23 Sep 2025 Issue date: 12 May 2022
Application
Utility: DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST External link
Filling date: 23 Sep 2025 Issue date: 12 May 2022
Application
Utility: 3-(1-OXO-5-(PIPERIDIN-4-YL)ISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF External link
Filling date: 23 Sep 2025 Issue date: 12 May 2022
Application
Utility: SUBSTITUTED 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF External link
Filling date: 23 Sep 2025 Issue date: 12 May 2022
Application
Utility: NEW MYOKINES AND USES THEREOF External link
Filling date: 23 Sep 2025 Issue date: 12 May 2022
Grant
Utility: Medical container with NFC antenna External link
Filling date: 23 Sep 2025 Issue date: 10 May 2022
Application
Utility: FLOW-THROUGH PARAMAGNETIC PARTICLE-BASED CELL SEPARATION AND PARAMAGNETIC PARTICLE REMOVAL External link
Filling date: 23 Sep 2025 Issue date: 5 May 2022
Application
Utility: COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3 External link
Filling date: 23 Sep 2025 Issue date: 5 May 2022
Application
Utility: PHARMACEUTICAL USE External link
Filling date: 23 Sep 2025 Issue date: 5 May 2022
Application
Utility: N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE External link
Filling date: 23 Sep 2025 Issue date: 28 Apr 2022
Grant
Utility: Methods for making conjugates from disulfide-containing proteins External link
Filling date: 23 Sep 2025 Issue date: 26 Apr 2022
Grant
Utility: Use of alpha 7 nicotinic acetylcholine receptor agonists External link
Filling date: 23 Sep 2025 Issue date: 26 Apr 2022
Grant
Utility: Antibodies against growth differentiation factor 15 and uses thereof External link
Filling date: 23 Sep 2025 Issue date: 26 Apr 2022
Application
Utility: ISOXAZOLE CARBOXAMIDE COMPOUNDS AND USES THEREOF External link
Filling date: 23 Sep 2025 Issue date: 21 Apr 2022
Application
Utility: LTA4H INHIBITORS FOR THE TREATMENT OF HIDRADENITIS SUPPURATIVA External link
Filling date: 23 Sep 2025 Issue date: 21 Apr 2022
Grant
Utility: Pharmaceutical compositions containing a DGAT1 inhibitor External link
Filling date: 23 Sep 2025 Issue date: 19 Apr 2022
Application
Utility: COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CRYPTOSPORIDIOSIS External link
Filling date: 23 Sep 2025 Issue date: 14 Apr 2022
Application
Utility: FUSED TRICYCLIC PYRAZOLO-DIHYDROPYRAZINYL-PYRIDONE COMPOUNDS AS ANTIVIRALS External link
Filling date: 23 Sep 2025 Issue date: 7 Apr 2022
Application
Utility: TECHNIQUE FOR DETERMINING A STATE OF MULTIPLE SCLEROSIS IN A PATIENT External link
Filling date: 23 Sep 2025 Issue date: 7 Apr 2022
Application
Utility: CYANOTRIAZOLE COMPOUNDS AND USES THEREOF External link
Filling date: 23 Sep 2025 Issue date: 7 Apr 2022
Grant
Utility: Pharmaceutical composition External link
Filling date: 23 Sep 2025 Issue date: 5 Apr 2022
Grant
Utility: Surgical probe with shape-memory material External link
Filling date: 23 Sep 2025 Issue date: 5 Apr 2022
Grant
Utility: Selective reduction of cysteine residues in IL-17 antibodies External link
Filling date: 23 Sep 2025 Issue date: 5 Apr 2022
Application
Utility: LIPOIC ACID CHOLINE ESTER COMPOSITIONS AND METHODS TO GENERATE BIOCOMPATIBLE OPHTHALMIC FORMULATIONS External link
Filling date: 23 Sep 2025 Issue date: 31 Mar 2022
Grant
Utility: Tracking movement of an eye within a tracking range External link
Filling date: 23 Sep 2025 Issue date: 29 Mar 2022
Application
Utility: CAR-EXPRESSING CELLS AGAINST MULTIPLE TUMOR ANTIGENS AND USES THEREOF External link
Filling date: 23 Sep 2025 Issue date: 24 Mar 2022
Application
Utility: SITE-SPECIFIC CHEMOENZYMATIC PROTEIN MODIFICATIONS External link
Filling date: 23 Sep 2025 Issue date: 24 Mar 2022
Application
Utility: COMPOUNDS AND COMPOSITIONS FOR INHBITING THE ACTIVITY OF SHP2 External link
Filling date: 23 Sep 2025 Issue date: 24 Mar 2022
Application
Utility: COMBINATION THERAPIES OF EGFRVIII CHIMERIC ANTIGEN RECEPTORS AND PD-1 INHIBITORS External link
Filling date: 23 Sep 2025 Issue date: 24 Mar 2022
Grant
Utility: Use of IL-17 antagonists to inhibit the progression of structural damage in psoriatic arthritis patients External link
Filling date: 23 Sep 2025 Issue date: 22 Mar 2022
Application
Utility: REGIMENS AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMAB External link
Filling date: 23 Sep 2025 Issue date: 17 Mar 2022
Grant
Utility: Diamino pyridine derivatives External link
Filling date: 23 Sep 2025 Issue date: 15 Mar 2022
Application
Utility: N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 External link
Filling date: 23 Sep 2025 Issue date: 10 Mar 2022
Application
Utility: Pharmaceutical Composition External link
Filling date: 23 Sep 2025 Issue date: 10 Mar 2022
Application
Utility: ORAL FORMULATIONS OF BRANAPLAM External link
Filling date: 23 Sep 2025 Issue date: 10 Mar 2022
Application
Utility: MACROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF DISEASE External link
Filling date: 23 Sep 2025 Issue date: 10 Mar 2022

Showing 100 to 150 of 1223 patents.